biopharma

5 things to know in life sciences: Week of March 16, 2026

FDA provides new guidance to replace animal testing in early drug studies. This and more in this week’s life sciences update. … READ MORE >

Mar. 18, 2026 by Amanda Laskey

The outcome of the case could unlock millions of pounds in VAT reclaims for U.S. biopharma companies with UK operations. … READ MORE >

Each week we highlight five things affecting the life sciences industry. Here’s the latest. … READ MORE >

Each week we highlight five things affecting the life sciences industry. Here’s the latest. … READ MORE >

Each week we highlight five things affecting the life sciences industry. Here’s the latest. … READ MORE >

Each week we highlight five things affecting the life sciences industry. Here’s the latest. … READ MORE >

AI is moving from experimentation to operational core in clinical trials. This and more in this week’s life sciences update. … READ MORE >

The FDA launches domestic drug manufacturing precheck program. This and more in this week’s life sciences industry update. … READ MORE >

Four key trends reshaping strategic M&A in biopharma. This and more in this week’s life sciences industry update. … READ MORE >

Three technologies shaping biotech in 2026. This and more in this week’s life sciences update. … READ MORE >